GUFICBIONSEGufic Biosciences Limited· PharmaceuticalsMediumNeutral
Announced Wed, 13 Aug · 19:49 IST

Gufic Biosciences Limited has informed the Exchange regarding Change in Auditors of the company.

Management Changes View source PDF

GUFICBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors of Gufic Biosciences has re-appointed M/s. Poddar & Co., Cost Accountants (Firm Registration No. 101734) as the Cost Auditors of the company for the financial year 2025-26. The firm is led by Mr. Sandeep Poddar, a qualified Cost Accountant with 15 years of experience across sectors including pharmaceuticals, chemicals, infrastructure, and telecommunications. This is a routine re-appointment and not a change in auditor, as confirmed in the Annexure. The disclosure has been made to BSE and NSE under SEBI Listing Regulations.

Likely market impact

This is a routine regulatory disclosure with no material impact on shareholders or the stock. Re-appointment of the existing cost auditor signals continuity in cost audit practices and is generally a neutral event for the stock.